Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer.
Phase 2
Recruiting
- Conditions
- non-squamous non-small cell lung cancer
- Registration Number
- JPRN-UMIN000008124
- Lead Sponsor
- iigata Lung Cancer Treatment Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of hemoptysis 2) High risk of bleeding or thrombus events 3) History of anticoagulant within 10 days before enrollment 4) Active radiation pneumonitis or esophagitis 5) Uncontrollable hypertension 6) Symptomatic brain metastasis 7) Scheduled operation 8) Severe complications 9) Problematic infection 10) History of active double cancer 11) No intention to birth control 12) Unstable psychic disorder 13) History of treatment drug 14) Decision of ineligibility by a physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PFS
- Secondary Outcome Measures
Name Time Method RR,DCR,OS,TTF,QOL,safety